Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,809 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00722228 | Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors | recruiting | Phase 1 / Phase 2 | 50 | Hadassah Medical OrganizationOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT05346848 | Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer(DARIUS) | recruiting | Phase 2 | 62 | Institut BergoniéOTHER | 1 | Oct 2, 2025 |
| clinicaltrials |
| NCT06824818 | Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients | recruiting | N/A | 155 | University of ChicagoOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT04512144 | Mindfulness in Endometrial and Cervical Cancer(MECCA) | recruiting | N/A | 120 | St. Louis UniversityOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT04111978 | MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)(MATAO) | recruiting | Phase 3 | 540 | Swiss GO Trial GroupNETWORK | 3 | Sep 29, 2025 | clinicaltrials |
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations(GENPROS) | recruiting | — | 4,260 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT05990803 | A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies | recruiting | Phase 2 | 130 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 26, 2025 | clinicaltrials |
| NCT06817668 | Evaluating Tolerability of ePUHRT With Brachytherapy Boost | recruiting | N/A | 31 | Indiana UniversityOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT06619769 | eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer(eSense-Cancer) | recruiting | N/A | 60 | University of British ColumbiaOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT07055165 | Connect2Care: Prostate Cancer Education and Screenings for African American Men | recruiting | N/A | 466 | University of OklahomaOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT05197881 | Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix(ARTIA-Cervix) | recruiting | N/A | 125 | Varian, a Siemens Healthineers CompanyINDUSTRY | 1 | Sep 23, 2025 | clinicaltrials |
| NCT05606133 | Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers | recruiting | N/A | 100 | Northwell HealthOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT05324332 | 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients | recruiting | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT05974774 | Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors | recruiting | Phase 3 | 1,600 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 19, 2025 | clinicaltrials |
| NCT07027046 | Application of da Vinci SP for Endometrial Cancer Surgical Staging | recruiting | — | 564 | National Cancer Institute, NaplesOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT06518746 | Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation | recruiting | N/A | 50 | University of Colorado, DenverOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT06731998 | Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery(LapTAP) | recruiting | N/A | 48 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07179783 | Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC) | recruiting | Phase 2 | 28 | Tianjin Medical University Second HospitalOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT05329532 | Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer(ModiFY) | recruiting | Phase 1 / Phase 2 | 168 | Scancell LtdINDUSTRY | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06152731 | HRD Tests for Ovarian cancER(HERO) | recruiting | Phase 2 | 88 | Centre Francois BaclesseOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT04794322 | Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer | recruiting | — | 250 | Massachusetts General HospitalOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT04858880 | Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.(PROPER2) | recruiting | N/A | 374 | Lund University HospitalOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT03958240 | Deciphering Mechanisms Underlying Cancer Immunogenicity(DECIDE) | recruiting | N/A | 1,100 | Institut Claudius RegaudOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07172685 | Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC | recruiting | N/A | 116 | Qilu Hospital of Shandong UniversityOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07078682 | An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms | recruiting | N/A | 42 | Zenchi, Inc.INDUSTRY | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07171528 | Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer(KOV-02S) | recruiting | Phase 2 | 80 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 12, 2025 | clinicaltrials |
| NCT03678025 | Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | recruiting | Phase 3 | 1,273 | SWOG Cancer Research NetworkNETWORK | 5 | Sep 11, 2025 | clinicaltrials |
| NCT06709534 | An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors | recruiting | N/A | 40 | Emory UniversityOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT07055399 | Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)(NICE-CC) | recruiting | Phase 2 | 43 | Fujian Cancer HospitalOTHER_GOV | 1 | Sep 11, 2025 | clinicaltrials |
| NCT05009082 | Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer | recruiting | Phase 3 | 970 | AGO Study GroupOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | recruiting | Phase 1 | 345 | Nurix Therapeutics, Inc.INDUSTRY | 2 | Sep 9, 2025 | clinicaltrials |
| NCT05600400 | Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer(iSMART) | recruiting | N/A | 144 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05786742 | Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.(HYPO-5) | recruiting | N/A | 205 | CHU de Quebec-Universite LavalOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06815354 | Comprehensive Assessment of Cancer Theranostic Response(TRAQinform) | recruiting | N/A | 32 | AIQ SolutionsINDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07162987 | Prehabilitation to Patients With Prostate Cancer(PREPP) | recruiting | N/A | 20 | Odense University HospitalOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07156253 | Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 110 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT06687421 | Implementation of Precision Medicine in High-risk Prostate Cancer(SPRINTR-REAL) | recruiting | — | 5,500 | Andreas JosefssonOTHER_GOV | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06689163 | A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone | recruiting | Phase 1 / Phase 2 | 66 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Sep 3, 2025 | clinicaltrials |
| NCT04555226 | The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) | recruiting | N/A | 452 | Chongqing University Cancer HospitalOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT07149831 | A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults | recruiting | Phase 1 | 6 | Sinotau Pharmaceutical GroupINDUSTRY | 1 | Sep 2, 2025 | clinicaltrials |
| NCT07148154 | Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations | recruiting | — | 3,000 | MiMARK Diagnostics, S.L.INDUSTRY | 1 | Aug 29, 2025 | clinicaltrials |
| NCT03878849 | Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer | recruiting | Phase 2 | 40 | Allarity TherapeuticsINDUSTRY | 1 | Aug 28, 2025 | clinicaltrials |
| NCT06331013 | CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr(PRO-SPEED) | recruiting | N/A | 60 | European Institute of OncologyOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT07146659 | Comparison of Operative Hysteroscopy Performed in the Operating Room Versus Outpatient Settings | recruiting | — | 400 | Centre Hospitalier Intercommunal CreteilOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT06134232 | Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T(ProvONE) | recruiting | Phase 2 | 400 | DendreonINDUSTRY | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06241846 | A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC | recruiting | Phase 2 | 100 | MediLink Therapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06683846 | Ivonescimab in the Treatment of Multiple Advanced Tumors | recruiting | Phase 2 | 400 | Fudan UniversityOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT05113368 | Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer | recruiting | Phase 2 | 31 | Sarah K. Lynam MDOTHER | 1 | Aug 21, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Oct 2, 2025source: clinicaltrials